+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ewing sarcoma: prognostic criteria, outcomes and future treatment

Ewing sarcoma: prognostic criteria, outcomes and future treatment

Expert Review of Anticancer Therapy 8(4): 617-624

Ewing sarcoma (EWS) is a bone tumor occurring primarily in adolescence and young adulthood. Multi-institutional clinical trials have improved the outcome for patients with nonmetastatic EWS, but not with metastatic EWS. Furthermore, although 30% of EWS recur, multi-institutional studies have not been completed for this high-risk group. Planning such studies has been hampered by both the lack of novel therapies and the inability to incorporate the biology of EWS. While the importance and detail of the EWS-FLI-1 translocation between chromosomes 11 and 22 are described, these have not yet led to new drug development for this orphan tumor. However, recent evidence supporting novel cytotoxic therapy, antiangiogenic therapy, and receptor-targeted therapy provides reason for optimism for patients with high-risk disease.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053107507

Download citation: RISBibTeXText

PMID: 18402528

DOI: 10.1586/14737140.8.4.617

Related references

Prognostic criteria of survival in the treatment of Ewing's sarcoma, reticulosarcoma and myeloma. Voprosy Onkologii 26(7): 9, 1980

Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. RadioTherapy and Oncology 10(2): 101-110, 1987

Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Medical and Pediatric Oncology 32(3): 186-195, 1999

Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Spine Journal 17(5): 645-655, 2017

Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma. Japanese Journal of Clinical Oncology 46(6): 522-528, 2016

Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors. Acta Orthopaedica Belgica 82(2): 216-221, 2016

Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience. Contemporary Oncology 20(2): 141-146, 2016

Ewing's sarcoma-treatment results and prognostic factors. Journal of the Medical Research Institute 16(2): 72-82, 1995

Treatment results and prognostic factors in Ewing sarcoma. Pediatric Hematology and Oncology 21(7): 597-610, 2005

Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome. Japanese Journal of Clinical Oncology 40(11): 1060-1067, 2010

Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. Pediatric Blood and Cancer 62(10): 1747-1753, 2015

Acute lymphoblastic leukemia arising after treatment of Ewing sarcoma was misdiagnosed as bone marrow metastasis of Ewing sarcoma: A case report. Medicine 97(3): E9644, 2018

Ewing's Sarcoma of the Stomach; Rare Case of Ewing's Sarcoma and Suggestion of New Treatment Strategy. Journal of Gastric Cancer 12(4): 258-261, 2012

Ewing's sarcoma of bone:treatment results and prognostic factors. Zhonghua Wai Ke Za Zhi 48(12): 896-899, 2010

Treatment results of the Ewing sarcoma of bone and prognostic factors. Pediatric Blood and Cancer 54(1): 19-24, 2010